North America 3d Bioprinting Market Size & Outlook

The 3d bioprinting market in North America is expected to reach a projected revenue of US$ 1,332.1 million by 2030. A compound annual growth rate of 9.6% is expected of North America 3d bioprinting market from 2024 to 2030.
Revenue, 2023 (US$M)
$702.4
Forecast, 2030 (US$M)
$1,332.1
CAGR, 2024 - 2030
9.6%
Report Coverage
North America

North America 3d bioprinting market highlights

  • The North America 3d bioprinting market generated a revenue of USD 702.4 million in 2023.
  • The market is expected to grow at a CAGR of 9.6% from 2024 to 2030.
  • In terms of segment, medical was the largest revenue generating application in 2023.
  • Dental is the most lucrative application segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 702.4 million
Market revenue in 2030USD 1,332.1 million
Growth rate9.6% (CAGR from 2023 to 2030)
Largest segmentMedical
Fastest growing segmentDental
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDental, Medical, Biosensors, Consumer/Personal Product Testing, Bioinks, Food and Animal Product
Key market players worldwideEnvisionTEC, Organovo Holdings Inc, 3D Systems Corp, Inventia Life, Poietis, Vivax Bio, Cyfuse Biomedical, Cellink, Regemat 3D


Other key industry trends

  • In terms of revenue, North America region accounted for 30.2% of the global 3d bioprinting market in 2023.
  • Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 1,908.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

3D Bioprinting Market Scope

3d bioprinting market segmentation & scope
Medical Implants
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Prosthetics
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Wearable Devices
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Tissue Engineering
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Others
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Orthopedic
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing
Neurology
End Use
Hospitals
Outpatient Facilities
Homecare
Research Manufacturing

3D Bioprinting Market Companies

Name Profile # Employees HQ Website

North America 3d bioprinting market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d bioprinting market will help companies and investors design strategic landscapes.


Medical was the largest segment with a revenue share of 38.51% in 2023. Horizon Databook has segmented the North America 3d bioprinting market based on dental, medical, biosensors, consumer/personal product testing, bioinks, food and animal product covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. FDA does not directly regulate 3D printers; its regulatory focus is on the manufacturing process and the output of 3D printers if that output qualifies as a medical device. The Center for Devices and Radiological Health (CDRH) has addressed regulating 3D-printed medical products through various means, including public forums, formal guidance, and presentations.


It is important to note that the FDA's guidance on this matter is subject to change due to the evolving nature of the technology. The regulatory pathway for 3D bio-printed products depends on their intended use, risk classification, and specific characteristics. Furthermore, the FDA is refining its regulatory framework for point-of-care 3D printing of medical devices (3DPOC). This innovative technology enables the localized and on-demand production of customized medical products for individual patients, utilizing their specific imaging data.


The potential advantages of this approach include enhancements in patient care, cost reduction, and expanded accessibility to medical products. However, the FDA's current regulatory framework for 3DPOC is not clear. The FDA has not yet issued any specific guidance on how 3DPOC devices should be regulated. This has led to uncertainty among manufacturers and providers about how to comply with the law.

Reasons to subscribe to North America 3d bioprinting market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America 3d bioprinting market databook

  • Our clientele includes a mix of 3d bioprinting market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America 3d bioprinting market , including forecasts for subscribers. This continent databook contains high-level insights into North America 3d bioprinting market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America 3d bioprinting market size, by country, 2018-2030 (US$M)

North America 3D Bioprinting Market Outlook Share, 2023 & 2030 (US$M)

North America 3d bioprinting market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more